Immune Function and the Progression to T1D
University of Florida · with Juvenile Diabetes Research Foundation, National Institute of Allergy and Infectious Diseases (NIAID) · NCT05899439
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 0 mo–100 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 2800
- US sites recruiting
- 3
- Study start
- January 1, 2005
- Record last updated
- April 9, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
To elucidate the mechanisms by which type 1 diabetes-associated genes; IFIH1, TYK2, IKZF4, as well as total genetic risk, impart functional immunoregulatory abnormalities that result in expansion of self-reactive adaptive immune cells, defective regulatory/effector mechanisms in T cells, inflammatory antigen presenting cells, and abnormal immune function in T cells and B cells.
Being studied: blood draw
Conditions: Type 1 Diabetes
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria: able to have blood drawn -
Exclusion Criteria: none
-
Recruiting US locations
Kieran McGrail
Gainesville, FL 32610
Site contact: Kieran McGrail · 352-273-9299 · mcgrail@pathology.ufl.edu
The Ohio State University
Columbus, OH 43210
Site contact: Billur Akkaya, MD DPhil · 614-688-1187 · billur.akkaya@osumc.edu
Baylor College of Medicine, Center for Research Advancement - Texas Children's Hospital
Houston, TX 77030
Site contact: Maria Redondo, MD, PhD, MPH · 832-822-1019 · redondo@bcm.edu
Study contacts (from the official record)
- Jennifer L Hosford, MPH · 352-294-5759 · jennifer.hosford@peds.ufl.edu
- Kieran McGrail · (352) 273-9299 · mcgrail@pathology.ufl.edu
Similar studies in Florida
All diabetes studies in Florida →- RecruitingHealthy volunteersPhase 1
Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)
Gilead Sciences
- Location
- Miami, FL + 2 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
Amgen
- Location
- Aventura, FL + 1 other US site
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersPhase 1
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
Ocugen
- Location
- Deerfield Beach, FL + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1
Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency
Sun Pharmaceutical Industries Limited
- Location
- Miami Lakes, FL
- Eligibility basics
- Ages 18–80